| Telix Pharmaceuticals Limited (TLX) ORDINARY FULLY PAID |
Health Care |
$4,654 |
Telix Provides Regulatory Update on TLX101-CDx
|
28 Apr 2025 8:33AM |
$28.560 |
$13.740 |
fallen by
51.89%
|
|
TLX - Price-sensitive ASX Announcement
Full Release
Key Points
- Telix Pharmaceuticals received a Complete Response Letter from the U.S. FDA for TLX101-CDx.
- The FDA requires additional confirmatory clinical evidence for the NDA to progress.
- There were no safety concerns raised by the FDA regarding TLX101-CDx.
- The company plans to request a hearing with the FDA to discuss the decision.
- Telix remains committed to addressing the unmet medical need for glioma imaging.
- TLX101-CDx has received Orphan Drug and Fast Track designations from the FDA.
- The outcome does not affect Telix's financial guidance for 2025.
- Telix will continue providing access to TLX101-CDx via the FDA-approved expanded access program.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Qoria Limited (QOR) ORDINARY FULLY PAID |
Information Technology |
$745 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
28 Apr 2025 8:33AM |
$0.355 |
$0.550 |
risen by
54.93%
|
|
QOR - Price-sensitive ASX Announcement
Full Release
Key Points
- Qoria Limited reported continued growth in SaaS recurring revenue for the quarter ended 30 June 2023.
- Customer onboarding remained strong, particularly in schools across Australia, New Zealand, the United States, and the United Kingdom.
- Strategic acquisitions were completed to expand the company’s product portfolio and market reach.
- Geographical expansion included further penetration into the US and UK education sectors.
- Customer retention rates remained high, reflecting satisfaction with Qoria's offerings.
- Product development efforts were intensified to enhance platform features and scalability.
- The company implemented ongoing cost management initiatives to improve operational efficiency.
- The Appendix 4C Cash Flow Report showed inflows from customers, investment in product development, administrative expenses, and acquisition costs.
- Qoria closed the quarter with a healthy cash balance, providing financial flexibility for future growth.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| L1 Long Short Fund Limited (LSF) ORDINARY FULLY PAID |
Financials |
$2,374 |
Net Tangible Asset Backing
|
28 Apr 2025 8:33AM |
$2.650 |
$3.750 |
risen by
41.51%
|
|
| ClearVue Technologies Limited (CPV) ORDINARY FULLY PAID |
Industrials |
$44 |
Quarterly Activities Report and Appendix 4C
|
28 Apr 2025 8:33AM |
$0.200 |
$0.145 |
fallen by
27.50%
|
|
CPV - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly Activities Report for ClearVue Technologies for the quarter ending 30 June 2023.
- Significant progress in US market expansion and commercial partnerships.
- Engagement in key projects, including installations in US schools and demonstration sites.
- Advancements in product certifications and technical development of PV window technologies.
- Cash receipts from customers for the quarter totaled AUD 177K.
- Research and development expenditures and operational outflows are detailed.
- Company maintains focus on global commercialization and prudent capital management.
- ClearVue continues to develop new product offerings and expand its partner network.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Develop Global Limited (DVP) ORDINARY FULLY PAID |
Materials |
$1,416 |
Quarterly Appendix 5B Cash Flow Report
|
28 Apr 2025 8:33AM |
$2.700 |
$4.290 |
risen by
58.89%
|
|
DVP - Price-sensitive ASX Announcement
Full Release
Key Points
- Develop Global Limited (DVP) released its Quarterly Activities and Appendix 5B Cash Flow Report for the period ending 31 December 2023.
- The report covers operational progress at the Woodlawn Project, including feasibility studies and permitting activities.
- Positive results were noted from recent metallurgical, geotechnical, and other technical studies at Woodlawn.
- The report details cash flows, including exploration, development, and administrative expenditures.
- The company's cash position at the end of the quarter is disclosed, along with expected spending for the next quarter.
- Updates are provided on both the Woodlawn and Sulphur Springs projects.
- Corporate events and strategic initiatives during the quarter are summarized.
- The Appendix 5B details company cash movements and balances.
- The report is intended for shareholders and stakeholders to provide transparency on financial and operational progress.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Bravura Solutions Limited (BVS) ORDINARY FULLY PAID |
Information Technology |
$1,116 |
CEO Change
|
28 Apr 2025 8:33AM |
$2.230 |
$2.490 |
risen by
11.66%
|
|
BVS - Price-sensitive ASX Announcement
Full Release
Key Points
- Bravura Solutions Limited (BVS) announced the appointment of Mr. Andrew Russell as CEO effective immediately.
- The change follows the departure of former CEO Ms. Libby Roy.
- Mr. Russell brings extensive experience in technology and financial services.
- The Board expressed confidence in Mr. Russell’s ability to lead the company’s next phase.
- The announcement includes thanks and recognition for Ms. Roy’s service and contributions to the company.
- Details about the succession planning and transition process are provided.
- The company reiterated its ongoing business priorities and strategic direction under new leadership.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Develop Global Limited (DVP) ORDINARY FULLY PAID |
Materials |
$1,416 |
Quarterly Activities Report
|
28 Apr 2025 8:33AM |
$2.700 |
$4.290 |
risen by
58.89%
|
|
DVP - Price-sensitive ASX Announcement
Full Release
Key Points
- Progress at the Sulphur Springs Copper-Zinc Project with feasibility and permitting activities ongoing.
- Continued exploration and drilling in the Greater Sulphur Springs area.
- Completion of the acquisition of Essential Metals Limited, adding lithium projects to the portfolio.
- Mining services division maintained strong revenue and contract pipeline.
- Company remains well-funded with robust cash position at quarter end.
- Focus on advancing resource project portfolio and leveraging mining services for growth.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Magellan Financial Group Limited (MFG) ORDINARY FULLY PAID |
Financials |
$1,624 |
Update - Notification of buy-back - MFG
|
28 Apr 2025 8:33AM |
$7.630 |
$9.560 |
risen by
25.29%
|
|
| FleetPartners Group Limited (FPR) ORDINARY FULLY PAID |
Financials |
$655 |
FY25 Half Year Results Release Date
|
28 Apr 2025 8:33AM |
$2.730 |
$3.030 |
risen by
10.99%
|
|
| GreenX Metals Limited (GRX) ORDINARY FULLY PAID |
Materials |
$255 |
Tannenberg Copper Project in Germany Expanded to 1,900km2
|
28 Apr 2025 8:33AM |
$0.755 |
$0.880 |
risen by
16.56%
|
|
GRX - Price-sensitive ASX Announcement
Full Release
Key Points
- GreenX Metals Limited expanded the Tannenberg Copper Project licence area to about 1,900 km².
- The project is now one of the largest copper exploration holdings in the European Union.
- Located in Saxony, Germany, the region is mining-friendly with established infrastructure.
- The expanded licence area covers multiple historic copper mining districts with documented past production.
- Evidence of cobalt mineralisation exists within the expanded project area.
- GreenX holds 100% of the project interest.
- The company plans to apply modern exploration techniques to evaluate copper and cobalt potential.
- Expansion aligns with growing EU demand and strategic importance of critical metals supply.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Native Mineral Resources Holdings Limited (NMR) ORDINARY FULLY PAID |
Materials |
$62 |
Major site works completed at Blackjack Gold Project
|
28 Apr 2025 8:33AM |
$0.155 |
$0.062 |
fallen by
60%
|
|
| Vinyl Group Ltd (VNL) ORDINARY FULLY PAID |
Information Technology |
$125 |
Notification of cessation of securities - VNL
|
28 Apr 2025 8:33AM |
$0.095 |
$0.090 |
fallen by
5.26%
|
|
| Santana Minerals Limited (SMI) ORDINARY FULLY PAID |
Materials |
$667 |
Quarterly Activities and Cashflow Reports
|
28 Apr 2025 8:32AM |
$0.560 |
$0.800 |
risen by
42.86%
|
|
SMI - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly report covers activities for the period ending March 31, 2024.
- Primary focus on the Bendigo-Ophir Project in Central Otago, New Zealand, wholly owned by SMI.
- Extensive diamond drilling program conducted, with significant results at Rise and Shine (RAS), Shreks, and Come-in-Time (CIT) prospects.
- Resource extension drilling completed, supporting the potential for further resource growth.
- No substantive mining production or mine development activities occurred during the quarter.
- Expenditure and cashflow summaries provided, showing ongoing investment in exploration and a robust cash position.
- Environmental and social responsibility initiatives continue to be a priority.
- Upcoming activities include continued drilling, resource definition, and exploration across the project area.
- Report includes Appendix 5B summarizing cash flows and related party payments.
- No payments were made to any mining or production-related activities during the period.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Far Limited (FAR) ORDINARY FULLY PAID |
Energy |
$38 |
Notice of Annual General Meeting/Proxy Form
|
28 Apr 2025 8:32AM |
$0.500 |
$0.415 |
fallen by
17%
|
|
| Far Limited (FAR) ORDINARY FULLY PAID |
Energy |
$38 |
Return of Capital - FAR
|
28 Apr 2025 8:32AM |
$0.500 |
$0.415 |
fallen by
17%
|
|
FAR - Price-sensitive ASX Announcement
Full Release
Key Points
- Far Limited proposes a return of capital to shareholders after the sale of the RSSD Project interest.
- The capital return will be 80 Australian cents per share, amounting to around AUD 444 million in total.
- The return will be effected as an equal reduction of capital, requiring shareholder approval.
- A shareholder meeting is scheduled to approve the proposed return of capital.
- The proposal outlines the rationale for returning surplus cash to shareholders.
- Guidance is provided to shareholders on potential tax implications of the capital return.
- A detailed timetable and process for the return of capital are included in the announcement.
- Shareholders are advised on how to participate and vote at the shareholder meeting.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Alliance Nickel Limited (AXN) ORDINARY FULLY PAID |
Materials |
$29 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
28 Apr 2025 8:32AM |
$0.036 |
$0.038 |
risen by
5.56%
|
|
AXN - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly activities focused on the NiWest Nickel-Cobalt Project in Western Australia.
- Completion of the Definitive Feasibility Study (DFS) enhances project economics and technical confidence.
- Progress made on offtake negotiations, notably with LG Energy Solution (LGES), advancing toward binding agreements.
- Ongoing discussions and due diligence with potential strategic partners for project financing.
- Permitting and environmental baseline studies continued to support project approvals.
- Community engagement and commitment to local employment and social responsibility initiatives.
- Financial summary provided, including cash balance at the end of the quarter and expenditure details.
- Appendix 5B Cash Flow Report included, detailing exploration, development, and corporate cash movements.
- Alliance Nickel Limited remains focused on developing the NiWest Project as a sustainable battery metals supplier.
- Company is positioning itself as a key contributor to the global energy transition and electric vehicle value chain.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ophir High Conviction Fund (OPH) ORDINARY UNITS FULLY PAID |
Financials |
$690 |
Weekly NTA 24.04.2025
|
28 Apr 2025 8:32AM |
$2.770 |
$3.100 |
risen by
11.91%
|
|
| Far Limited (FAR) ORDINARY FULLY PAID |
Energy |
$38 |
Quarterly Activities Report and Appendix 5B
|
28 Apr 2025 8:32AM |
$0.500 |
$0.415 |
fallen by
17%
|
|
FAR - Price-sensitive ASX Announcement
Full Release
Key Points
- FAR Limited continues exploration activities offshore The Gambia, particularly regarding the A2 and A5 blocks.
- The company drilled the Bambo-1 well and sidetracked to the Bambo-1ST1 well, both of which encountered oil shows but were deemed non-commercial.
- Discussions are ongoing regarding a potential farm-out of FAR's interests in The Gambia to fund future appraisal drilling.
- FAR is working to finalize the sale of its entire interest in the Sangomar Field Development to Woodside Energy, with completion expected upon satisfaction of conditions precedent.
- Cash at the end of the quarter was US$46.4 million, with detailed expenditure outlined in the Appendix 5B.
- There are no significant production or development operations as FAR's focus remains on exploration and asset transactions.
- The company is actively managing costs and maintains a disciplined approach to capital allocation.
- FAR is evaluating new opportunities in the energy sector while prioritizing value creation from its existing portfolio.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| MAAS Group Holdings Limited (MGH) ORDINARY FULLY PAID |
Industrials |
$1,633 |
Update - Notification of buy-back - MGH
|
28 Apr 2025 8:32AM |
$3.850 |
$4.490 |
risen by
16.62%
|
|
| Alara Resources Limited (AUQ) ORDINARY FULLY PAID |
Materials |
$28 |
16th Copper Concentrate Shipment Dispatched
|
28 Apr 2025 8:32AM |
$0.026 |
$0.035 |
risen by
34.62%
|
|
| Top End Energy Limited (TEE) ORDINARY FULLY PAID |
Energy |
$9 |
Operating License Awarded
|
28 Apr 2025 8:32AM |
$0.077 |
$0.032 |
fallen by
58.44%
|
|
TEE - Price-sensitive ASX Announcement
Full Release
Key Points
- Top End Energy Limited (TEE) has been awarded an Operating Licence for its project in the Northern Territory.
- The licence enables TEE to proceed with exploration and development activities in the licensed area.
- TEE acknowledges and thanks stakeholders and regulators for their support during the application process.
- The announcement details the regulatory and environmental compliance aspects associated with the licence.
- Securing the licence is described as a strategic milestone for TEE's growth and project advancement.
- Next steps and future plans for the exploration and development phase are outlined in the document.
- TEE reiterates its commitment to responsible resource development and maintaining high operational standards.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Dimerix Limited (DXB) ORDINARY FULLY PAID |
Health Care |
$360 |
FDA confirms Proteinuria as Primary Endpoint for US approval
|
28 Apr 2025 8:32AM |
$0.455 |
$0.600 |
risen by
31.87%
|
|
DXB - Price-sensitive ASX Announcement
Full Release
Key Points
- FDA has confirmed proteinuria as a primary endpoint for DMX-200 approval in the US.
- DMX-200 is being developed by Dimerix Limited for the treatment of focal segmental glomerulosclerosis (FSGS).
- Confirmation from the FDA provides a clear regulatory path for Phase 3 clinical trials.
- Proteinuria as an endpoint aligns Dimerix’s clinical development with FDA expectations.
- The decision helps de-risk Dimerix’s US regulatory and development pathway.
- This milestone is expected to support stakeholder confidence and company strategy for US market entry.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Hearts and Minds Investments Limited (HM1) ORDINARY FULLY PAID |
Financials |
$733 |
Weekly NTA Estimate
|
28 Apr 2025 8:31AM |
$2.760 |
$3.200 |
risen by
15.94%
|
|
| Capral Limited (CAA) ORDINARY FULLY PAID |
Materials |
$209 |
Update - Notification of buy-back - CAA
|
28 Apr 2025 8:31AM |
$9.170 |
$12.840 |
risen by
40.02%
|
|
| Galilee Energy Limited (GLL) ORDINARY FULLY PAID |
Energy |
$6 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
28 Apr 2025 8:31AM |
$0.007 |
$0.007 |
fallen by
7.14%
|
|
GLL - Price-sensitive ASX Announcement
Full Release
Key Points
- Galilee Energy continued production testing at Glenaras Gas Project with updated water and gas rate performance.
- Operational focus on improving gas production and reviewing stimulation strategies.
- Assessment of Glenaras production data and planning for further field development.
- Engagement with potential partners and evaluation of strategic options for project advancement.
- Prudent financial management with detailed quarterly cash flow disclosures in Appendix 5B.
- Cash outflows primarily related to project development, exploration, and corporate costs.
- Closing cash balance and anticipated expenditure for the upcoming quarters outlined.
- Commitment to ongoing business development and communication with stakeholders.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
